India  

54.72 lakh Covid-19 vaccine doses received till Tuesday afternoon: Centre

IndiaTimes Tuesday, 12 January 2021 ()
The Centre said 54.72 lakh Covid-19 vaccine doses have been received at designated national and state-level stores till Tuesday afternoon, and all the shots -- 1.1 crore from the Serum Institute of India and 55 lakh from Bharat Biotech -- will be received by January 14.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: Around 5.56 lakh COVID vaccine doses dispatched from Pune: TN Principal Health Secy

Around 5.56 lakh COVID vaccine doses dispatched from Pune: TN Principal Health Secy 02:22

On January 12, the Principal Secretary of Health and Family Welfare Department of Tamil Nadu, J Radhakrishnan spoke on COVID-19 vaccine distribution process. He said, "Around 5.56 lakh vaccine doses have been dispatched from Pune. We will be receiving the vaccines at around 10.30 am on January 12....

You Might Like


💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published
Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Nepal: People cheers after approval of Covishield vaccine manufactured in India [Video]

Nepal: People cheers after approval of Covishield vaccine manufactured in India

After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on Friday issued a release giving information on approving Covishield developed by AstraZeneca and Oxford University, which will be manufactured by Serum Institute of India (SII) in India. Drug regulating authority has also specified Serum Institute of India for importers provided with low cost in purchasing and delivery of vaccine to public. Approving the vaccine for conditional purpose, the department has also asked manufacturers or importers to get approval for registration in order to bring the vaccines. Nepal imposed nationwide and partial lockdown for most of 2020 with rise in imported cases which later took the form of local transmission spreading mostly in urban areas and major cities. The nationwide lockdown which started in March 2020 hampered daily life of people as well as businesses. They now expect to thrive with the approval of vaccine. Though the detailed inoculation plan of Nepal Government is yet to be disclosed, a total of 3 companies applied for approval to take steps forward with Serum Institute for import of vaccines. India has already made conditional emergency approval for Covishield manufactured by the Serum Institute. Being one of the largest producers of vaccines at low cost, India has promised to provide vaccine to its neighbours in near future.

Credit: ANI    Duration: 02:39Published

Related videos from verified sources

COVID-19 vaccination to be done at 81 locations in Delhi on Jan 16: Delhi Govt [Video]

COVID-19 vaccination to be done at 81 locations in Delhi on Jan 16: Delhi Govt

Ahead of COVID-19 vaccination drive, Delhi Chief Minister Arvind Kejriwal announced that the drive will be held at 81 locations in the national capital on January 16 and it will later increase to 175..

Credit: ANI     Duration: 01:44Published
Over 3 lakh Covisheild doses reach Raipur [Video]

Over 3 lakh Covisheild doses reach Raipur

A consignment of COVID-19 vaccine, Covishield arrived at Raipur from Serum Institute of India, Pune on January 13. SII had dispatched vaccines across India on January 12. Raipur received 23, 300 vials..

Credit: ANI     Duration: 01:37Published
5.06 lakh doses of Covishield vaccine arrives at Bhopal airport [Video]

5.06 lakh doses of Covishield vaccine arrives at Bhopal airport

A consignment of COVID-19 vaccine, Covishield arrived at Bhopal airport from Serum Institute of India, Pune. "We have received 5.06 lakh doses of vaccine. We have made 1,200 storage systems at state..

Credit: ANI     Duration: 01:41Published